AACR logo

More articles from Priority Brief

Activation of CD8+ T cells contributes to anti-tumor effects of CDK4/6 inhibitors plus MEK inhibitors
Jessica LF Teh, Dan A Erkes, Phil F. Cheng, Manoela Tiago, Nicole A Wilski, Conroy O Field, Inna Chervoneva, Mitchell P. Levesque, Xiaowei Xu, Reinhard Dummer, Andrew E Aplin

Cancer Immunology Research Jan 2020, canimm.0743.2019; DOI: 10.1158/2326-6066.CIR-19-0743
Remodeling Translation Primes CD8⁺ T-cell Antitumor Immunity
Katie E. Hurst, Kiley A. Lawrence, Rob A. Robino, Lauren E. Ball, Dongjun Chung, Jessica E. Thaxton

Cancer Immunology Research May 2020, 8 (5) 587-595; DOI: 10.1158/2326-6066.CIR-19-0516
Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
Ashleigh R. Poh, Amy R. Dwyer, Moritz F. Eissmann, Ashwini L. Chand, David Baloyan, Louis Boon, Michael W. Murrey, Lachlan Whitehead, Megan O'Brien, Clifford A. Lowell, Tracy L. Putoczki, Fiona J. Pixley, Robert J.J. O'Donoghue, Matthias Ernst

Cancer Immunology Research Apr 2020, 8 (4) 428-435; DOI: 10.1158/2326-6066.CIR-19-0623
Tumor Cell–Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer
Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Taiji Yamazoe, Andrés Blanco, Ben Z. Stanger

Cancer Immunology Research Mar 2020, 8 (3) 282-291; DOI: 10.1158/2326-6066.CIR-19-0661
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
James W. Welsh, Chad Tang, Patricia de Groot, Aung Naing, Kenneth R. Hess, John V. Heymach, Vassiliki A. Papadimitrakopoulou, Taylor R. Cushman, Vivek Subbiah, Joe Y. Chang, George R. Simon, Rishab Ramapriyan, Hampartsoum B. Barsoumian, Hari Menon, Maria Angelica Cortez, Erminia Massarelli, Quynh Nguyen, Padmanee Sharma, James P. Allison, Adi Diab, Vivek Verma, Uma Raju, Sherif G. Shaaban, Ramona Dadu, Maria E. Cabanillas, Kelvin Wang, Clark Anderson, Daniel R. Gomez, Stephen Hahn, Ritsuko Komaki, David S. Hong

Cancer Immunology Research Dec 2019, 7 (12) 1903-1909; DOI: 10.1158/2326-6066.CIR-18-0793
USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity
Xing Huang, Qi Zhang, Yu Lou, Junli Wang, Xinyu Zhao, Lin Wang, Xiaozhen Zhang, Shanshan Li, Yulan Zhao, Qi Chen, Tingbo Liang, Xueli Bai

Cancer Immunology Research Oct 2019, 7 (10) 1580-1590; DOI: 10.1158/2326-6066.CIR-18-0910
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang, Karan Kohli, R. Graeme Black, Lu Yao, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Seth M. Pollack

Cancer Immunology Research Aug 2019, 7 (8) 1237-1243; DOI: 10.1158/2326-6066.CIR-18-0940
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
Sarah E. Josefsson, Klaus Beiske, Yngvild N. Blaker, Mette S. Førsund, Harald Holte, Bjørn Østenstad, Eva Kimby, Hakan Köksal, Sébastien Wälchli, Baoyan Bai, Erlend B. Smeland, Ronald Levy, Arne Kolstad, Kanutte Huse, June H. Myklebust

Cancer Immunology Research Mar 2019, 7 (3) 355-362; DOI: 10.1158/2326-6066.CIR-18-0351
Restoration of Endogenous Retrovirus Infectivity Impacts Mouse Cancer Models
Eleonora Ottina, Prisca Levy, Urszula Eksmond, Julia Merkenschlager, George R. Young, Juliette Roels, Jonathan P. Stoye, Thomas Tüting, Dinis P. Calado, George Kassiotis

Cancer Immunology Research Nov 2018, 6 (11) 1292-1300; DOI: 10.1158/2326-6066.CIR-18-0038
NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors
Christa I. DeVette, Massimo Andreatta, Wilfried Bardet, Steven J. Cate, Vanessa I. Jurtz, Kenneth W. Jackson, Alana L. Welm, Morten Nielsen, William H. Hildebrand

Cancer Immunology Research Jun 2018, 6 (6) 636-644; DOI: 10.1158/2326-6066.CIR-17-0298

Main menu

User menu

Search

More articles from Priority Brief

Pages

Articles

Info for

About Cancer Immunology Research